Bharat Hospitals Profile
Key Indicators
- Authorised Capital ₹ 3.00 Cr
as on 18-12-2024
- Paid Up Capital ₹ 2.07 Cr
as on 18-12-2024
- Company Age 17 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 10.50 Cr
as on 18-12-2024
- Revenue %
(FY 2020)
- Profit -1055603.31%
(FY 2020)
- Ebitda -1065285.15%
(FY 2020)
- Net Worth -109.58%
(FY 2020)
- Total Assets -87.35%
(FY 2020)
About Bharat Hospitals
The Company is engaged in the Business Outsourcing Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 3.00 Cr and a paid-up capital of Rs 2.07 Cr.
The company currently has active open charges totaling ₹10.50 Cr.
Nidhi Singhal, Kamlesh Rani, and Mangat Mittal serve as directors at the Company.
- CIN/LLPIN
U85194DL2007PLC163861
- Company No.
163861
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
24 May 2007
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Bharat Hospitals?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nidhi Singhal  | Additional Director | 11-Mar-2017 | Current |
| Kamlesh Rani | Additional Director | 11-Mar-2017 | Current |
| Mangat Mittal | Additional Director | 11-Mar-2017 | Current |
Financial Performance and Corporate Structure Insights of Bharat Hospitals.
Bharat Hospitals Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 1055603.31% decrease in profit. The company's net worth observed a substantial decline by a decrease of 109.58%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Bharat Hospitals?
In 2020, Bharat Hospitals had a promoter holding of 100.00%. The company had 1 Subsidiary and 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
R.P. Welltar LimitedActive 14 years 1 monthNidhi Singhal, Kamlesh Rani and 1 more are mutual person
- R.P. Gums & Chemcials LimitedActive 14 years 1 month
Kamlesh Rani and Mangat Mittal are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Oriental Bank Of Commerce Creation Date: 13 Nov 2013 | ₹10.50 Cr | Open |
How Many Employees Work at Bharat Hospitals?
Unlock and access historical data on people associated with Bharat Hospitals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bharat Hospitals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bharat Hospitals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
